Development and validation of a multimodal predictive model based on clinical, biochemical, and quantitative dual-energy CT parameters: for predicting the benignity and malignancy of thyroid nodules - Takeaways - MDSpire

Development and validation of a multimodal predictive model based on clinical, biochemical, and quantitative dual-energy CT parameters: for predicting the benignity and malignancy of thyroid nodules

  • By

  • Yafei Zhang

  • Congyan Yin

  • Ranran Huang

  • Guowei Zhang

  • Xuhong Pan

  • June 24, 2026

  • 0 min

Share

  • 1

    A predictive model was developed to differentiate malignant from benign thyroid nodules using clinical, biochemical, and DECT parameters.

  • 2

    The study included 172 patients, with 87 malignant and 85 benign thyroid nodules, confirmed by histopathology.

  • 3

    Independent predictors of malignancy identified were age, TSH levels, and thyroid nodule volume, with specific odds ratios reported.

  • 4

    The final model achieved an AUC of 0.866 in the training cohort and 0.852 in the validation cohort, indicating good discriminative performance.

  • 5

    The multimodal model may enhance risk stratification and reduce unnecessary interventions in the management of thyroid nodules.

Original Source(s)

Development and validation of a multimodal predictive model based on clinical, biochemical, and quantitative dual-energy CT parameters: for predicting the benignity and malignancy of thyroid nodules

  • by Yafei Zhang, Congyan Yin, Ranran Huang, Guowei Zhang, Xuhong Pan

  • June 24, 2026

Related Content

Expression patterns of carbonic anhydrase IX and immune response biomarkers in pediatric gliomas and glioneuronal tumors

Evaluation of the CIB1R peptide derived from the cytoplasmic domain of neprilysin on cell migration in an in vitro model of lung cancer

Patient Perspectives on Electronic Communication of Cancer Diagnoses